Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam, ciprofol, and propofol with low-dose sufentanil in hysteroscopic surgery
ChiCTR2300069105Phase 4Not yet recruiting
- Sponsor
- Lishui People's Hospital
- Start
- Apr 2023
- Modality
- Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in perioperative pain, Procedural anxiety and None comparing Remimazolam + low-dose sufentanil, Ciprofol + low-dose sufentanil and Propofol + low-dose sufentanil (3 arms). Primary endpoints: Blood pressure, Oxygen saturation and 2 more. Planned start Apr 2023; status: not yet recruiting.
02
Drugs
remimazolamciprofolpropofol
03
Conditions
perioperative painProcedural anxiety
Beyond the preview
Go deeper on ChiCTR2300069105.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300069105.